These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 31878968)
21. Relation of Odor Identification with Alzheimer's Disease Markers in Cerebrospinal Fluid and Cognition. Reijs BLR; Ramakers IHGB; Elias-Sonnenschein L; Teunissen CE; Koel-Simmelink M; Tsolaki M; Wahlund LO; Waldemar G; Hausner L; Johannsen P; Vanderstichele H; Verhey F; Devanand DP; Visser PJ J Alzheimers Dis; 2017; 60(3):1025-1034. PubMed ID: 28984603 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. Wang L; Benzinger TL; Su Y; Christensen J; Friedrichsen K; Aldea P; McConathy J; Cairns NJ; Fagan AM; Morris JC; Ances BM JAMA Neurol; 2016 Sep; 73(9):1070-7. PubMed ID: 27454922 [TBL] [Abstract][Full Text] [Related]
23. Neuropsychological Profiles and Trajectories in Preclinical Alzheimer's Disease. Ho JK; Nation DA; J Int Neuropsychol Soc; 2018 Aug; 24(7):693-702. PubMed ID: 29706146 [TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers. Lane EM; Hohman TJ; Jefferson AL; Brain Imaging Behav; 2017 Dec; 11(6):1779-1786. PubMed ID: 27817134 [TBL] [Abstract][Full Text] [Related]
25. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies. Podhorna J; Krahnke T; Shear M; Harrison JE; Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820 [TBL] [Abstract][Full Text] [Related]
26. Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment. Malpas CB; Saling MM; Velakoulis D; Desmond P; O'Brien TJ; J Alzheimers Dis; 2015; 47(4):965-75. PubMed ID: 26401775 [TBL] [Abstract][Full Text] [Related]
27. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study. Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097 [TBL] [Abstract][Full Text] [Related]
28. Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age. Allison SL; Jonaitis EM; Koscik RL; Hermann BP; Mueller KD; Cary RP; Ma Y; Rowley HA; Carlsson CM; Asthana S; Zetterberg H; Blennow K; Bendlin BB; Johnson SC Neurobiol Aging; 2021 Jun; 102():151-160. PubMed ID: 33765428 [TBL] [Abstract][Full Text] [Related]
29. Informants' Perception of Subjective Cognitive Decline Helps to Discriminate Preclinical Alzheimer's Disease from Normal Aging. Valech N; Mollica MA; Olives J; Tort A; Fortea J; Lleo A; Belén SS; Molinuevo JL; Rami L J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S87-98. PubMed ID: 26445275 [TBL] [Abstract][Full Text] [Related]
30. Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels. López-Martos D; Brugulat-Serrat A; Cañas-Martínez A; Canals-Gispert L; Marne P; Gramunt N; Suárez-Calvet M; Milà-Alomà M; Minguillon C; Fauria K; Zetterberg H; Blennow K; Gispert JD; Molinuevo JL; Grau-Rivera O; Sánchez-Benavides G; J Alzheimers Dis; 2023; 95(1):237-249. PubMed ID: 37483000 [TBL] [Abstract][Full Text] [Related]
32. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. Gold BT; Zhu Z; Brown CA; Andersen AH; LaDu MJ; Tai L; Jicha GA; Kryscio RJ; Estus S; Nelson PT; Scheff SW; Abner E; Schmitt FA; Van Eldik LJ; Smith CD Neurobiol Aging; 2014 Oct; 35(10):2263-71. PubMed ID: 24866404 [TBL] [Abstract][Full Text] [Related]
33. CSF tau markers are correlated with hippocampal volume in Alzheimer's disease. de Souza LC; Chupin M; Lamari F; Jardel C; Leclercq D; Colliot O; Lehéricy S; Dubois B; Sarazin M Neurobiol Aging; 2012 Jul; 33(7):1253-7. PubMed ID: 21489655 [TBL] [Abstract][Full Text] [Related]